JESSICA WYCKOFF: Open Payments
NPI 1205451366 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,290 in 61 payments from 16 companies in 2025. Trend: 2023 $977 · 2024 $1,067 · 2025 $2,290
Food & beverage: $2,177Education: $114
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $630 |
| Regeneron Healthcare Solutions, Inc. | 8 | $500 |
| Botanix SB Inc | 7 | $187 |
| Novartis Pharmaceuticals Corporation | 4 | $175 |
| Arcutis Biotherapeutics, Inc. | 1 | $146 |
| Incyte Corporation | 5 | $116 |
| Janssen Biotech, Inc. | 4 | $114 |
| GENZYME CORPORATION | 3 | $100 |
| Lilly USA, LLC | 3 | $88 |
| Amgen Inc. | 3 | $70 |
Products named: DUPIXENT, ILUMYA, SOFDRA, Zoryve, Rhapsido, LEVULAN KERASTICK, OPZELURA, TREMFYA.
Industry payments across FL — which companies pay providers there.
